Salinomycin: A new paradigm in cancer therapy
J Dewangan, S Srivastava, SK Rath - Tumor Biology, 2017 - journals.sagepub.com
The primary hurdle in the treatment of cancer is acquisition of resistance by the tumor cells
toward multiple drugs and selectively targeting the cancer stem cells. This problem was …
toward multiple drugs and selectively targeting the cancer stem cells. This problem was …
Therapeutic applications and biological activities of bacterial bioactive extracts
Z Abdelghani, N Hourani, Z Zaidan, G Dbaibo… - Archives of …, 2021 - Springer
Bacteria are rich in a wide variety of secondary metabolites, such as pigments, alkaloids,
antibiotics, and others. These bioactive microbial products serve a great application in …
antibiotics, and others. These bioactive microbial products serve a great application in …
Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo
J Dewangan, S Srivastava, S Mishra, A Divakar… - Biochemical …, 2019 - Elsevier
Cancer is a complex disease wherein cells begin to divide abnormally and spread into
surrounding tissues. Angiogenesis plays a crucial role in tumor progression as it is required …
surrounding tissues. Angiogenesis plays a crucial role in tumor progression as it is required …
Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer
A Markowska, S Sajdak, J Markowska… - European journal of …, 2017 - Elsevier
Failure in ovarian cancer therapy, following cytoreduction and chemotherapy, is related to
the presence of cancer stem cells-a small subpopulation of cells resistant to chemotherapy …
the presence of cancer stem cells-a small subpopulation of cells resistant to chemotherapy …
Salinomycin and its derivatives–A new class of multiple-targeted “magic bullets”
M Antoszczak, A Huczyński - European Journal of Medicinal Chemistry, 2019 - Elsevier
The history of drug development clearly shows the scale of painstaking effort leading to a
finished product–a highly biologically active agent that would be at the same time no or little …
finished product–a highly biologically active agent that would be at the same time no or little …
Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways
Aims Histone deacetylases inhibitors have shown favorable antitumor activity in clinical
investigations. In the present study, we assessed the effects of a novel hydroxamic acid …
investigations. In the present study, we assessed the effects of a novel hydroxamic acid …
MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals
Q Lv, JX Hu, YJ Li, N Xie, DD Song, W Zhao… - Cancer biology & …, 2017 - Taylor & Francis
MicroRNAs play important roles in tumorigenesis of various types of cancers. MiR-320a can
inhibits cell proliferation of some cancers, but the biologic roles of miR-320a in lung cancer …
inhibits cell proliferation of some cancers, but the biologic roles of miR-320a in lung cancer …
A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents
M Antoszczak - European Journal of Medicinal Chemistry, 2019 - Elsevier
Polyether ionophore antibiotics (ionophores) represent a large group of more than 120 lipid-
soluble compounds that are widely used in veterinary medicine because of their significant …
soluble compounds that are widely used in veterinary medicine because of their significant …
Salinomycin triggers prostate cancer cell apoptosis by inducing oxidative and endoplasmic reticulum stress via suppressing Nrf2 signaling
J Yu, Y Yang, S Li, P Meng - Experimental and …, 2021 - spandidos-publications.com
Salinomycin is a polyether antiprotozoal antibiotic that is widely used as an animal food
additive. Some antifungal, antiparasitic, antiviral and anti‑inflammatory activities have been …
additive. Some antifungal, antiparasitic, antiviral and anti‑inflammatory activities have been …
A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
M Antoszczak - European Journal of Medicinal Chemistry, 2019 - Elsevier
Tumors are phenotypically heterogeneous and include a small sub-population of cancer
cells (2–5% of the tumor mass) with stem-cell like properties. The cancer stem cell …
cells (2–5% of the tumor mass) with stem-cell like properties. The cancer stem cell …